The findings of this study can serve as the basis for future experiments and studies aiming to normalize tumor cell vasculature through the eradication of CSCs and can promote the development of therapeutic strategies based on the inhibition of BTK-mTOR signaling to improve the treatment of chemoresistant/radioresistant GBM. This evidence concerns the gene BTK and neoplasm.